| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |